High homocysteine is associated with increased risk of colorectal cancer independently of oxidative stress and antioxidant capacities

Clinical Nutrition

Volumn 33, Issue 6, 2014, Pages 1054-1060

  Chiang, Feng Fan ^a   Wang, Hwei Ming ^a   Lan, Yu Chun ^b,c   Yang, Min Hsiu ^b,c   Huang, Shih Chien ^d   Huang, Yi Chia ^b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Antioxidant capacities; Colorectal cancer; Cysteine; Homocysteine; Oxidative stress; Pyridoxal 5' phosphate

Indexed keywords

CYSTEINE; FOLIC ACID; GLUTATHIONE TRANSFERASE; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE; ANTIOXIDANT; CREATININE; GLUTATHIONE PEROXIDASE; SERUM ALBUMIN; SUPEROXIDE DISMUTASE;

ADULT; AMINO ACID BLOOD LEVEL; ANTIOXIDANT ASSAY; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; AGED; BLOOD; BLOOD PRESSURE; BODY MASS; COLORECTAL NEOPLASMS; DRUG EFFECTS; METABOLISM; MIDDLE AGED; NORMAL HUMAN; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; ANTIOXIDANTS; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CREATININE; CYSTEINE; FEMALE; FOLIC ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HEALTHY VOLUNTEERS; HOMOCYSTEINE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PYRIDOXAL PHOSPHATE; RISK FACTORS; SERUM ALBUMIN; SUPEROXIDE DISMUTASE;

EID: 84920167946     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.11.007     Document Type: Article

References (35)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. 12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999, 8:825-829.
3. Ulvik A., Vollset S.E., Hansen S., Gislefoss R., Jellum E., Ueland P.M. Colorectal cancer and the methylenetetrahydrofolate reductase 677C→T and methionine synthase 2756A→G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004, 13:2175-2180.
4. Maffei F., Angeloni C., Malaguti M., Moraga J.M.Z., Pasqui F., Poli C., et al. Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk. Mutat Res 2011, 714:88-92.
5. Leufkens A.M., van Duijnhoven F.J., Woudt S.H., Siersema P.D., Jenab M., Jansen E.H.J.M., et al. Biomarkers of oxidative stress and risk of developing colorectal cancer: a cohort-nested case-control study in the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol 2012, 175:653-663.
6. Strzelczyk J.K., Wielkoszyński T., Krakowczyk Ł., Adamek B., Zalewska-Ziob M., Gawron K., et al. The activity of antioxidant enzymes in colorectal adenocarcinoma and corresponding normal mucosa. Acta Biochim Pol 2012, 59:549-556.
7. Hoffman M. Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress. Med Hypotheses 2011, 77:1088-1093.
8. Stipanuk M.H. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr 2004, 24:539-577.
9. Stipanuk M.H., Dominy J.E., Lee J.I., Coloso R.M. Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism. JNutr 2006, 136:1652S-1659S.
10. Hogg N. The effect of cyst(e)ine on the auto-oxidation of homocysteine. Free Radic Biol Med 1999, 27:28-33.
11. Dudman N.P., Guo X.W., Crooks R., Xie L., Silberberg J.S. Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2-oxa-1, 3-diazole-4-sulfonic acid derivative, and use of appropriate calibrators. Clin Chem 1996, 42:2028-2032.
12. Selhub J., Jacques P.F., Wilson P.W., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAm Med Assoc 1993, 270:2693-2698.
13. Talwar D., Quasim T., McMillan D.C., Kinsella J., Williamson C., O'Reilly D.S.J. Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation. JChromatogr B 2003, 792:333-343.
14. Food and Nutrition Board - Institute of Medicine Dietary reference intakes. Thiamin, riboflavin, niacin, vitamin B-6, folate, vitamin B-12, pantothenic acid, biotin, and choline 1998, National Academy Press, Washington, DC.
15. Lapenna D., Ciofani G., Pierdomenico S.D., Giamberardino M.A., Cuccurullo F. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 2001, 31:331-335.
16. Erel O. Anovel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004, 37:277-285.
17. Blau S., Rubinstein A., Bass P., Singaram C., Kohen R. Differences in the reducing power along the rat GI tract: lower antioxidant capacity of the colon. Mol Cell Biochem 1999, 194:185-191.
18. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991, 51:794-798.
19. Signorello M.G., Viviani G.L., Armani U., Cerone R., Minniti G., Piana A., et al. Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 2006, 120:607-613.
20. Wu L.L., Wu J.T. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 2002, 322:21-28.
21. Nishio E., Watanabe Y. Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide. Br J Pharmacol 1997, 122:269-274.
22. Huang R.F., Hsu Y.C., Lin H.L., Yang F.L. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. JNutr 2001, 131:33-38.
23. Kato I., Dnistrian A.M., Schwartz M., Toniolo P., Koenig K., Shore R.E., et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 1999, 79:1917-1921.
24. Kaji E., Kato J., Saito S., Harada K., Kuwaki K., Tatsukawa M., et al. Serum folate and homocysteine levels are associated with colon tumorigenesis in end-stage renal disease patients. Nutr Cancer 2011, 63:202-211.
25. Miller J.W., Beresford S.A.A., Neuhouser M.L., Cheng T.-Y.D., Song X., Brown E.C., et al. Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort. Am J Clin Nutr 2013, 97:827-834.
26. Le Marchand L., White K.K., Nomura A.M., Wilkens L.R., Selhub J.S., Tiirikainen M., et al. Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009, 18:2195-2201.
27. Weinstein S.J., Albanes D., Selhub J., Graubard B., Lim U., Taylor P.R., et al. One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 2008, 17:3233-3240.
28. Faintuch J., Aguilar P.B., Nadalin W. Relevance of N-acetylcysteine in clinical practice: fact, myth or consequence?. Nutrition 1999, 15:177-179.
29. Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. JNutr Health Aging 2002, 6:39-42.
30. Le Marchand L., Wang H., Selhub J., Vogt T.M., Yokochi L., Decker R. Association of plasma vitamin B6 with risk of colorectal adenoma in a multiethnic case-control study. Cancer Causes Control 2011, 22:929-936.
31. Zschäbitz S., Cheng T.Y.D., Neuhouser M.L., Zheng Y., Ray R.M., Miller J.W., et al. Bvitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. Am J Clin Nutr 2013, 97:332-343.
32. Otani T., Iwasaki M., Hanaoka T., Kobayashi M., Ishihara J., Natsukawa S., et al. Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer 2005, 53:42-50.
33. 6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol 2006, 163:108-115.
34. 2-treated U937 monocytes. Free Radic Biol Med 2004, 36:423-428.
35. 2 in vascular endothelial cells in culture. Int J Vitam Nutr Res 2009, 79:218-219.